Author

Chen-Hsiang Lee

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:clinical cohort / trial· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Cheng-Kun Wu· 1 shared Chien-Hua Chiu· 1 shared Chih-Fang Huang· 1 shared Chih-Ming Liang· 1 shared Deng-Chyang Wu· 1 shared Hsiang Tso Huang· 1 shared Hsin-Ming Wang· 1 shared Kai-Lung Tsai· 1 shared

Activity by Year

2018-2018 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

Cheng-Kun Wu

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

The efficacy of a 14-day modified quadruple therapy containing amoxicillin, tetracycline and high dose metronidazole and proton-pump inhibitors as an empirical third line helicobacter pylori eradication treatment in Taiwan

Hsiang Tso Huang, Chih-Ming Liang, Chen-Hsiang Lee, Wei-Chen Tai, Cheng-Kun Wu, Shih-Cheng Yang, Chih-Fang Huang, Chien-Hua Chiu, Kai-Lung Tsai, Meng-wei Chang, Hsin-Ming Wang, Keng-Liang Wu, Ping-I Hsu, Deng-Chyang Wu, Seng-Kee Chuah, on behalf of Taiwan Acid-Related Disease (TARD) Study Group

This study evaluates a 14-day modified quadruple therapy for H. pylori eradication in patients with treatment failure, finding lower efficacy compared to culture-guided therapy.

bioRxiv · May 22, 2018 · PreprintMicrobiology